Kadcyla (trastuzumab emtansine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Kadcyla (trastuzumab emtansine), covering 2016-08-11 to 2016-08-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer [Phase 2, Phase 3]